 | • レポートコード：QYR9NV01722 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、バイオ医薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、組換えタンパク質、顆粒球コロニー刺激因子（G-CSF）、インターフェロン、組換えヒトインスリン、エリスロポエチン、ワクチン、成長ホルモン、精製タンパク質、その他に、用途別には、代謝障害、腫瘍学、神経障害、心血管疾患、炎症性および感染症、その他にセグメント区分し、バイオ医薬品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・バイオ医薬品の世界市場概要 ・バイオ医薬品の製造コスト構成分析 ・バイオ医薬品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・バイオ医薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・バイオ医薬品のセグメント分析（種類別） （モノクローナル抗体、組換えタンパク質、顆粒球コロニー刺激因子（G-CSF）、インターフェロン、組換えヒトインスリン、エリスロポエチン、ワクチン、成長ホルモン、精製タンパク質、その他） ・バイオ医薬品のセグメント分析（用途別） （代謝障害、腫瘍学、神経障害、心血管疾患、炎症性および感染症、その他） ・バイオ医薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Pfizer、F. Hoffmann-La Roche AG、Johnson & Johnson Services、Sanofi, Amgen、AbbVie、Merck & Co., Inc、Biogen Idec、Bayer AG、Eli Lilly and Company、Novartis AG GlaxoSmithKline Plc、Bristol-Myers Squibb Company、AstraZeneca PLC、Abbott Laboratories、） ・バイオ医薬品の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Bio-pharma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Bio-pharma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-pharma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-pharma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-pharma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Segment by Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Table of Contents
Executive Summary
1 Industry Overview of Bio-pharma
1.1 Definition of Bio-pharma
1.2 Bio-pharma Segment by Type
1.2.1 Global Bio-pharma Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.5 Interferons
1.2.6 Recombinant Human Insulin
1.2.7 Erythropoietin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Purified Proteins
1.2.11 Others
1.3 Bio-pharma Segment by Applications
1.3.1 Global Bio-pharma Consumption Comparison by Applications (2014-2025)
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 Global Bio-pharma Overall Market
1.4.1 Global Bio-pharma Revenue (2014-2025)
1.4.2 Global Bio-pharma Production (2014-2025)
1.4.3 North America Bio-pharma Status and Prospect (2014-2025)
1.4.4 Europe Bio-pharma Status and Prospect (2014-2025)
1.4.5 China Bio-pharma Status and Prospect (2014-2025)
1.4.6 Japan Bio-pharma Status and Prospect (2014-2025)
1.4.7 Southeast Asia Bio-pharma Status and Prospect (2014-2025)
1.4.8 India Bio-pharma Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bio-pharma
2.3 Manufacturing Process Analysis of Bio-pharma
2.4 Industry Chain Structure of Bio-pharma
3 Development and Manufacturing Plants Analysis of Bio-pharma
3.1 Capacity and Commercial Production Date
3.2 Global Bio-pharma Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Bio-pharma
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Bio-pharma Production and Capacity Analysis
4.2 Bio-pharma Revenue Analysis
4.3 Bio-pharma Price Analysis
4.4 Market Concentration Degree
5 Bio-pharma Regional Market Analysis
5.1 Bio-pharma Production by Regions
5.1.1 Global Bio-pharma Production by Regions
5.1.2 Global Bio-pharma Revenue by Regions
5.2 Bio-pharma Consumption by Regions
5.3 North America Bio-pharma Market Analysis
5.3.1 North America Bio-pharma Production
5.3.2 North America Bio-pharma Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Bio-pharma Import and Export
5.4 Europe Bio-pharma Market Analysis
5.4.1 Europe Bio-pharma Production
5.4.2 Europe Bio-pharma Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Bio-pharma Import and Export
5.5 China Bio-pharma Market Analysis
5.5.1 China Bio-pharma Production
5.5.2 China Bio-pharma Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Bio-pharma Import and Export
5.6 Japan Bio-pharma Market Analysis
5.6.1 Japan Bio-pharma Production
5.6.2 Japan Bio-pharma Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Bio-pharma Import and Export
5.7 Southeast Asia Bio-pharma Market Analysis
5.7.1 Southeast Asia Bio-pharma Production
5.7.2 Southeast Asia Bio-pharma Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Bio-pharma Import and Export
5.8 India Bio-pharma Market Analysis
5.8.1 India Bio-pharma Production
5.8.2 India Bio-pharma Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Bio-pharma Import and Export
6 Bio-pharma Segment Market Analysis (by Type)
6.1 Global Bio-pharma Production by Type
6.2 Global Bio-pharma Revenue by Type
6.3 Bio-pharma Price by Type
7 Bio-pharma Segment Market Analysis (by Application)
7.1 Global Bio-pharma Consumption by Application
7.2 Global Bio-pharma Consumption Market Share by Application (2014-2019)
8 Bio-pharma Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Bio-pharma Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 F. Hoffmann-La Roche AG
8.2.1 F. Hoffmann-La Roche AG Bio-pharma Production Sites and Area Served
8.2.2 F. Hoffmann-La Roche AG Product Introduction, Application and Specification
8.2.3 F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson Services
8.3.1 Johnson & Johnson Services Bio-pharma Production Sites and Area Served
8.3.2 Johnson & Johnson Services Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Services Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanofi, Amgen
8.4.1 Sanofi, Amgen Bio-pharma Production Sites and Area Served
8.4.2 Sanofi, Amgen Product Introduction, Application and Specification
8.4.3 Sanofi, Amgen Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AbbVie
8.5.1 AbbVie Bio-pharma Production Sites and Area Served
8.5.2 AbbVie Product Introduction, Application and Specification
8.5.3 AbbVie Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck & Co., Inc
8.6.1 Merck & Co., Inc Bio-pharma Production Sites and Area Served
8.6.2 Merck & Co., Inc Product Introduction, Application and Specification
8.6.3 Merck & Co., Inc Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Biogen Idec
8.7.1 Biogen Idec Bio-pharma Production Sites and Area Served
8.7.2 Biogen Idec Product Introduction, Application and Specification
8.7.3 Biogen Idec Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bayer AG
8.8.1 Bayer AG Bio-pharma Production Sites and Area Served
8.8.2 Bayer AG Product Introduction, Application and Specification
8.8.3 Bayer AG Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Eli Lilly and Company
8.9.1 Eli Lilly and Company Bio-pharma Production Sites and Area Served
8.9.2 Eli Lilly and Company Product Introduction, Application and Specification
8.9.3 Eli Lilly and Company Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis AG GlaxoSmithKline Plc
8.10.1 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Sites and Area Served
8.10.2 Novartis AG GlaxoSmithKline Plc Product Introduction, Application and Specification
8.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Bristol-Myers Squibb Company
8.12 AstraZeneca PLC
8.13 Abbott Laboratories
9 Development Trend of Analysis of Bio-pharma Market
9.1 Global Bio-pharma Market Trend Analysis
9.1.1 Global Bio-pharma Market Size (Volume and Value) Forecast 2019-2025
9.2 Bio-pharma Regional Market Trend
9.2.1 North America Bio-pharma Forecast 2019-2025
9.2.2 Europe Bio-pharma Forecast 2019-2025
9.2.3 China Bio-pharma Forecast 2019-2025
9.2.4 Japan Bio-pharma Forecast 2019-2025
9.2.5 Southeast Asia Bio-pharma Forecast 2019-2025
9.2.6 India Bio-pharma Forecast 2019-2025
9.3 Bio-pharma Market Trend (Product Type)
9.4 Bio-pharma Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Bio-pharma Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Bio-pharma
Table Global Bio-pharma Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Bio-pharma Production Market Share by Types in 2018
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Table Global Bio-pharma Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Bio-pharma Consumption Market Share by Applications in 2018
Figure Metabolic Disorders
Figure Oncology
Figure Neurological Disorders
Figure Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases
Figure Others
Figure Global Bio-pharma Revenue (Million USD) (2014-2025)
Figure Global Bio-pharma Production (K Pcs) (2014-2025)
Figure North America Bio-pharma Market Size (Million USD) (2014-2025)
Figure Europe Bio-pharma Market Size (Million USD) (2014-2025)
Figure China Bio-pharma Market Size (Million USD) (2014-2025)
Figure Japan Bio-pharma Market Size (Million USD) (2014-2025)
Figure Southeast Asia Bio-pharma Market Size (Million USD) (2014-2025)
Figure India Bio-pharma Market Size (Million USD) (2014-2025)
Table Bio-pharma Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bio-pharma in 2018
Figure Manufacturing Process Analysis of Bio-pharma
Figure Industry Chain Structure of Bio-pharma
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Bio-pharma Manufacturing Plants Distribution
Table Bio-pharma Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Bio-pharma Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Bio-pharma Production (K Pcs) of Major Manufacturers (2014-2019)
Table Bio-pharma Production Market Share of Major Manufacturers (2014-2019)
Figure Bio-pharma Production Share by Manufacturers in 2018
Table Bio-pharma Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Bio-pharma Revenue Market Share of Major Manufacturers (2014-2019)
Figure Bio-pharma Revenue Share by Manufacturers in 2018
Table Bio-pharma Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Bio-pharma Production by Regions 2014-2019 (K Pcs)
Table Global Bio-pharma Production Market Share by Regions 2014-2019
Figure Global Bio-pharma Production Market Share by Regions in 2018
Table Global Bio-pharma Revenue by Regions 2014-2019 (Million USD)
Table Global Bio-pharma Revenue Market Share by Regions 2014-2019
Figure Global Bio-pharma Revenue Market Share by Regions in 2018
Table Global Bio-pharma Consumption by Regions 2014-2019 (K Pcs)
Table Global Bio-pharma Consumption Market Share by Regions 2014-2019
Figure North America Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure North America Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table North America Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure Europe Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure China Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure China Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table China Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure Japan Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure India Bio-pharma Production Growth Rate 2014-2019 (K Pcs)
Figure India Bio-pharma Revenue Growth Rate 2014-2019 (Million USD)
Table India Bio-pharma Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Bio-pharma Market Share by Application (2014-2019)
Figure Global Value (Consumption) Bio-pharma Market Share by Application (2014-2019)
Table Pfizer Bio-pharma Production Sites and Area Served
Table Pfizer Bio-pharma Product Introduction, Application and Specification
Table Pfizer Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Bio-pharma Production Growth Rate (2014-2019)
Table Pfizer Bio-pharma Production Market Share (2014-2019)
Figure Pfizer Bio-pharma Revenue Market Share (2014-2019)
Table Pfizer Bio-pharma Main Business and Markets Served
Table F. Hoffmann-La Roche AG Bio-pharma Production Sites and Area Served
Table F. Hoffmann-La Roche AG Bio-pharma Product Introduction, Application and Specification
Table F. Hoffmann-La Roche AG Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Bio-pharma Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche AG Bio-pharma Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche AG Bio-pharma Main Business and Markets Served
Table Johnson & Johnson Services Bio-pharma Production Sites and Area Served
Table Johnson & Johnson Services Bio-pharma Product Introduction, Application and Specification
Table Johnson & Johnson Services Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Services Bio-pharma Production Growth Rate (2014-2019)
Table Johnson & Johnson Services Bio-pharma Production Market Share (2014-2019)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share (2014-2019)
Table Johnson & Johnson Services Bio-pharma Main Business and Markets Served
Table Sanofi, Amgen Bio-pharma Production Sites and Area Served
Table Sanofi, Amgen Bio-pharma Product Introduction, Application and Specification
Table Sanofi, Amgen Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi, Amgen Bio-pharma Production Growth Rate (2014-2019)
Table Sanofi, Amgen Bio-pharma Production Market Share (2014-2019)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share (2014-2019)
Table Sanofi, Amgen Bio-pharma Main Business and Markets Served
Table AbbVie Bio-pharma Production Sites and Area Served
Table AbbVie Bio-pharma Product Introduction, Application and Specification
Table AbbVie Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Bio-pharma Production Growth Rate (2014-2019)
Table AbbVie Bio-pharma Production Market Share (2014-2019)
Figure AbbVie Bio-pharma Revenue Market Share (2014-2019)
Table AbbVie Bio-pharma Main Business and Markets Served
Table Merck & Co., Inc Bio-pharma Production Sites and Area Served
Table Merck & Co., Inc Bio-pharma Product Introduction, Application and Specification
Table Merck & Co., Inc Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc Bio-pharma Production Growth Rate (2014-2019)
Table Merck & Co., Inc Bio-pharma Production Market Share (2014-2019)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share (2014-2019)
Table Merck & Co., Inc Bio-pharma Main Business and Markets Served
Table Biogen Idec Bio-pharma Production Sites and Area Served
Table Biogen Idec Bio-pharma Product Introduction, Application and Specification
Table Biogen Idec Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Idec Bio-pharma Production Growth Rate (2014-2019)
Table Biogen Idec Bio-pharma Production Market Share (2014-2019)
Figure Biogen Idec Bio-pharma Revenue Market Share (2014-2019)
Table Biogen Idec Bio-pharma Main Business and Markets Served
Table Bayer AG Bio-pharma Production Sites and Area Served
Table Bayer AG Bio-pharma Product Introduction, Application and Specification
Table Bayer AG Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Bio-pharma Production Growth Rate (2014-2019)
Table Bayer AG Bio-pharma Production Market Share (2014-2019)
Figure Bayer AG Bio-pharma Revenue Market Share (2014-2019)
Table Bayer AG Bio-pharma Main Business and Markets Served
Table Eli Lilly and Company Bio-pharma Production Sites and Area Served
Table Eli Lilly and Company Bio-pharma Product Introduction, Application and Specification
Table Eli Lilly and Company Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Bio-pharma Production Growth Rate (2014-2019)
Table Eli Lilly and Company Bio-pharma Production Market Share (2014-2019)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share (2014-2019)
Table Eli Lilly and Company Bio-pharma Main Business and Markets Served
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Production Sites and Area Served
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Product Introduction, Application and Specification
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Production Growth Rate (2014-2019)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Production Market Share (2014-2019)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share (2014-2019)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Main Business and Markets Served
Table Bristol-Myers Squibb Company Bio-pharma Production Sites and Area Served
Table AstraZeneca PLC Bio-pharma Production Sites and Area Served
Table Abbott Laboratories Bio-pharma Production Sites and Area Served
Figure Global Bio-pharma Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Bio-pharma Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Bio-pharma Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Bio-pharma Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Bio-pharma Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Bio-pharma by Type (2019-2025)
Table Global Consumption (K Pcs) of Bio-pharma by Application (2019-2025)
Table Bio-pharma Distributors List
Table Bio-pharma Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界及び中国の顆粒球コロニー刺激因子市場2018 The 'Global and Chinese Granulocyte Colony Stimulating Factor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Granulocyte Colony Stimulating Factor industry with a focus on the Chinese market. The report provides key statistics on t…- 世界及び中国の顆粒球マクロファージコロニー刺激因子市場2018 The 'Global and Chinese Granulocyte Macrophage Colony Stimulating Factor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Granulocyte Macrophage Colony Stimulating Factor industry with a focus on the Chinese market. The report provid…
- 顆粒球マクロファージコロニー刺激因子のグローバル市場調査 2019年 The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regiona…
- G-CSFバイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. Scope of the Report: This report focuses on the G-CSF Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and …
- 組換えペプチドのグローバル市場調査 2019年 The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, th…